Pulse Biosciences, Inc.
PLSE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | -224.4% | – | – | – |
| R&D Expenses | $11 | $12 | $10 | $11 |
| G&A Expenses | $0 | $8 | $8 | $10 |
| SG&A Expenses | $9 | $8 | $8 | $10 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | $0 | $0 |
| Operating Expenses | $20 | $20 | $18 | $20 |
| Operating Income | -$20 | -$20 | -$18 | -$20 |
| % Margin | -23,682.6% | – | – | – |
| Other Income/Exp. Net | $1 | $1 | $1 | $1 |
| Pre-Tax Income | -$19 | -$19 | -$17 | -$19 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$19 | -$19 | -$17 | -$19 |
| % Margin | -22,540.7% | – | – | – |
| EPS | -0.29 | -0.28 | -0.25 | -0.33 |
| % Growth | -3.6% | -12% | 24.2% | – |
| EPS Diluted | -0.29 | -0.28 | -0.25 | -0.33 |
| Weighted Avg Shares Out | 67 | 67 | 67 | 58 |
| Weighted Avg Shares Out Dil | 67 | 67 | 67 | 58 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $1 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$19 | -$19 | -$18 | -$20 |
| % Margin | -22,243% | – | – | – |